In the conventional model of metastasis progression, both CD133+ and CD133− cancer cells are released into the bloodstream when metastasis is initiated [42], but only CD133+ cells are able to survive and initialize tumor colonization (Figure 5, upper panel). This evidence concerns the gene PROM1 and neoplasm.